Note from June 29, 2020
Although we do not yet know how long the social distancing related to the Covid-19 pandemic will last, and regardless of the changes that had to be made in the evaluation of the June 2020 session in relation to what is provided for in this learning unit description, new learnig unit evaluation methods may still be adopted by the teachers; details of these methods have been - or will be - communicated to the students by the teachers, as soon as possible.
Although we do not yet know how long the social distancing related to the Covid-19 pandemic will last, and regardless of the changes that had to be made in the evaluation of the June 2020 session in relation to what is provided for in this learning unit description, new learnig unit evaluation methods may still be adopted by the teachers; details of these methods have been - or will be - communicated to the students by the teachers, as soon as possible.
3 credits
22.5 h
Q2
Teacher(s)
des Rieux Anne; Préat Véronique (coordinator); Vanbever Rita;
Language
French
Main themes
The new drug delivery systems addressed during the classes include transdermal and transmucosal drug delivery, nanocarriers (liposomes, nanoparticles), drug delivery in tissue engineering, the solubilisation of poorly soluble drugs.
Aims
At the end of this learning unit, the student is able to : | |
| 1 | By the end of the course, the students should be able to design of new drug delivery systems for drugs with low oral bioavailability. |
The contribution of this Teaching Unit to the development and command of the skills and learning outcomes of the programme(s) can be accessed at the end of this sheet, in the section entitled “Programmes/courses offering this Teaching Unit”.
Content
Interactive lecture courses during which the concepts are illustrated by many examples.
Other information
Prerequisite: physicochemistry, pharmaocokinetics
Evaluation: written exam
Course materials available on icampus
Faculty or entity
FARM
